Anabolic steroids are synthetic derivatives of clinical effects and side effects demonstratethe androgenic properties of this class of drugs. Was not achieved complete dissociation of anabolic and androgenic effects. The actions of anabolic steroids are therefore similar to those of male sex hormones with the possibility of serious disturbances of growth and sexual development if given to young children. Anabolic steroids suppress gonadotropic functions of the pituitary and may exert a direct effect on the testes. During exogenous administration of anabolic androgens,
endogenous testosterone release is inhibited by inhibition of the pituitary luteinizing hormone (LH). In large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).
Anabolic steroids have been reported to increase low-density lipoproteins and high-density lipoproteins. This return to normal levels after discontinuation of treatment.
Pharmacom Labs Oxandrolonos is presented in a 100 tablet box with 2 blister packs of 50 tablets each. Each tablet reportedly contains 10 milligrams of oxandrolone according to the label and packaging. Samples of this product were purchased from a North American-based authorized distributor between the dates of June 1, 2015 and June 30, 2015. The samples were forwarded and received by the analytical laboratory SIMEC AG for HPLC-UV testing on July 20, 2015. The quantitative dosage testing report was completed on August 10, 2015. The product was identified with an expiration date of October 15, 2018 and a batch number of MBMN1. There was no verification code printed on the box.